Viewing Study NCT04710134


Ignite Creation Date: 2025-12-25 @ 2:30 AM
Ignite Modification Date: 2025-12-30 @ 10:42 AM
Study NCT ID: NCT04710134
Status: COMPLETED
Last Update Posted: 2024-01-25
First Post: 2021-01-08
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy of Reslizumab Dose Escalation in Patients With Severe Asthma
Sponsor: McMaster University
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module